It is tempting to speculate that Gal-4-BGA6 interactions may contribute to modulation of IL-6-dependent inflammatory responses in a wide range of immune-mediated pathologies, including autoimmune disorders, chronic infection, fibrosis and cancer. Here, LGALS4 is linked to cancer.